ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 123 filers reported holding ENDOCYTE INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $20,000 | -4.8% | 14,200 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $21,000 | -41.7% | 14,200 | 0.0% | 0.01% | -53.8% |
| Q1 2017 | $36,000 | 0.0% | 14,200 | 0.0% | 0.01% | -27.8% |
| Q4 2016 | $36,000 | -18.2% | 14,200 | 0.0% | 0.02% | +50.0% |
| Q3 2016 | $44,000 | -4.3% | 14,200 | 0.0% | 0.01% | -29.4% |
| Q2 2016 | $46,000 | +4.5% | 14,200 | 0.0% | 0.02% | +21.4% |
| Q1 2016 | $44,000 | -22.8% | 14,200 | 0.0% | 0.01% | +16.7% |
| Q4 2015 | $57,000 | -12.3% | 14,200 | 0.0% | 0.01% | -67.6% |
| Q3 2015 | $65,000 | -12.2% | 14,200 | 0.0% | 0.04% | -5.1% |
| Q2 2015 | $74,000 | -16.9% | 14,200 | 0.0% | 0.04% | -39.1% |
| Q1 2015 | $89,000 | 0.0% | 14,200 | 0.0% | 0.06% | -5.9% |
| Q4 2014 | $89,000 | +3.5% | 14,200 | 0.0% | 0.07% | +6.2% |
| Q3 2014 | $86,000 | -8.5% | 14,200 | 0.0% | 0.06% | -9.9% |
| Q2 2014 | $94,000 | +118.6% | 14,200 | +256.3% | 0.07% | +61.4% |
| Q4 2013 | $43,000 | – | 3,985 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |